母体与新生儿维生素D结合蛋白、维生素D水平、维生素D受体基因型与儿童1型糖尿病
该研究基于超过10万对母婴队列,分析189对儿童后续发生1型糖尿病(T1D)的母婴对和576对随机对照,检测分娩时及孕中期母体血浆和脐血的25(OH)D与维生素D结合蛋白(DBP),并对维生素D代谢通路基因分型。结果发现分娩时母体DBP水平较高与子代T1D风险降低相关,脐血25(OH)D较高与T1D风险降低相关且受VDR rs11568820基因型修饰。结论提示母体DBP和新生儿25(OH)D可能影响子代T1D风险,需其他研究重复验证。
要点
- 分娩时母体DBP每升高1 μmol/L,子代T1D风险OR为0.86(95%CI 0.74-0.98)。
- 携带VDR rs11568820 G/G基因型的儿童中,脐血25(OH)D每升高10 nmol/L,T1D风险OR为0.87(95%CI 0.77-0.98)。
- 25(OH)D水平与rs11568820的交互作用P=0.01,其他基因-环境交互未检出。
核心结论
- 分娩时母体DBP水平较高可能降低子代T1D风险。
- 出生时25(OH)D水平较高可能降低T1D风险,但取决于VDR基因型。
研究设计与样本
- 从超过10万对母婴队列中分析189对子代后续发生T1D的母婴对和576对随机对照。
- 采用液相色谱-串联质谱法检测25(OH)D,多克隆放射免疫法检测DBP,样本为分娩时及孕中期的母体血浆和脐血。
- 对母婴进行维生素D代谢相关基因(GC、DHCR7、CYP2R1、CYP24A1、CYP27B1、VDR)变异分型,并使用logistic回归估计校正潜在混杂因素后的OR值。
主要发现
- 分娩时母体DBP每升高1 μmol/L,子代T1D风险OR为0.86(95%CI 0.74-0.98),其他样本DBP无显著关联。
- 携带VDR rs11568820 G/G基因型的儿童中,脐血25(OH)D每升高10 nmol/L,T1D风险OR为0.87(95%CI 0.77-0.98)。
- 25(OH)D水平与rs11568820的交互作用P=0.01。
- 未检出其他基因-环境交互作用。
临床怎么用
- 临床关注孕期及新生儿维生素D状态时,可考虑结合VDR基因型和DBP水平评估子代T1D风险。
- 未来维生素D与T1D相关研究应纳入VDR基因型和DBP水平。
局限性
- 研究结果需在其他研究中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Circumstantial evidence links 25-hydroxy vitamin D [25(OH)D], vitamin D-binding protein (DBP), vitamin D-associated genes, and type 1 diabetes (T1D), but no studies have jointly analyzed these. We aimed to investigate whether DBP levels during pregnancy or at birth were associated with offspring T1D and whether vitamin D pathway genetic variants modified associations between DBP, 25(OH)D, and T1D. RESEARCH DESIGN AND METHODS: From a cohort of >100,000 mother/child pairs, we analyzed 189 pairs where the child later developed T1D and 576 random control pairs. We measured 25(OH)D using liquid chromatography-tandem mass spectrometry, and DBP using polyclonal radioimmunoassay, in cord blood and maternal plasma samples collected at delivery and midpregnancy. We genotyped mother and child for variants in or near genes involved in vitamin D metabolism (GC, DHCR7, CYP2R1, CYP24A1, CYP27B1, and VDR). Logistic regression was used to estimate odds ratios (ORs) adjusted for potential confounders. RESULTS: Higher maternal DBP levels at delivery, but not in other samples, were associated with lower offspring T1D risk (OR 0.86 [95% CI 0.74-0.98] per μmol/L increase). Higher cord blood 25(OH)D levels were associated with lower T1D risk (OR = 0.87 [95% CI 0.77-0.98] per 10 nmol/L increase) in children carrying the VDR rs11568820 G/G genotype (P interaction = 0.01 between 25(OH)D level and rs11568820). We did not detect other gene-environment interactions. CONCLUSIONS: Higher maternal DBP level at delivery may decrease offspring T1D risk. Increased 25(OH)D levels at birth may decrease T1D risk, depending on VDR genotype. These findings should be replicated in other studies. Future studies of vitamin D and T1D should include VDR genotype and DBP levels.
引用
- Tapia G, Mårild K, Dahl SR, et al. Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes. Diabetes Care. 2019. PMID: 30692241. doi:10.2337/dc18-2176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。